NCT03715465View on ClinicalTrials.gov

The Clinical Utility of Measuring the Circadian Clock in Treatment of Delayed Sleep-Wake Phase Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

February 15, 2019

Primary Completion Date

November 5, 2021

Study Completion Date

November 5, 2021

Conditions
Delayed Sleep Phase Syndrome
Interventions
DRUG

Melatonin 0.5 MG

Melatonin tablet

OTHER

Dim Light Melatonin Onset (salivary)

Test to determine the time of melatonin onset in saliva under dim light conditions

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

American Academy of Sleep Medicine

OTHER

lead

University of Michigan

OTHER

NCT03715465 - The Clinical Utility of Measuring the Circadian Clock in Treatment of Delayed Sleep-Wake Phase Disorder | Biotech Hunter | Biotech Hunter